| Friday, November 29th 2024 |
Is Your Favorite Pharmacy About To Go Belly Up? |
Walgreens Boots Alliance stands at a critical juncture in the company's 170-year history with revenues of $147 billion but a market capitalization of just $7 billion. A heavily burdened balance sheet has been the prime culprit of the stock's downfall but, under new CEO Tim Wentworth, management is undertaking an ambitious realignment aimed at stabilizing the core pharmacy business while taking the chop to some of its healthcare investments. Get the full details here |
Ivy Content you May Have Missed
|
30% Upside for Leader in Market Growing 30% Annually?
|
Renowned e-signature company DocuSign, Inc. (NASDAQ:DOCU) has got firmly back on track after some turbulence in 2021 and 2022 when the company's share price declined by more than 75%. The recent stock performance has fared much better, begging the question where is the ceiling for this once hot stock? Get the full details here |
4 Stocks Behind Bill Gates $45 Billion Portfolio
|
The Bill & Melinda Gates Foundation is a philanthropic powerhouse that lists among its accomplishments the total eradication of two types of polio virus, improving agricultural outcomes in impoverished countries and delivering health services to millions worldwide. Get the full details here |
37.9% Upside In Overlooked AI Stock |
Some concerns have arisen in recent months that the fuel behind the AI fire is starting to wane. The flagship AI stock, NVIDIA, gained 156% through the first six months of the year, but Nvidia shares only gained 18.8% since the midpoint of 2024. While that is still substantial growth, it reflects investors' concerns about AI's ability to generate substantial revenue. Get the full details here |
|
 |
|
| | Advertising Disclosure: This email may contain paid advertisements. Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world. We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com. Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here. If you can't see this message, view it in your browser. You are receiving this e-mail at edwardlorilla1986.paxforex@blogger.com as a part of your free subscription to the Ivy Newsletter. To read our privacy policy follow this link. or To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311 Website: Summa Money Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Copyright 2024 Summa Money. All rights reserved. Advertise With Us |
|
|
In order to unsubscribe from this mailing list, please click
here 
No comments:
Post a Comment